Clinical Case File: Group A Streptococcus

by | Clinical, Molecular

Publish Date: September 20, 2018

Cold and flu season is right around the corner. These annual illnesses are often paired with another highly contagious infection, strep throat. Its culprit, Group A Streptococcus, can cause a variety of other illnesses including invasive diseases such as cellulitis with blood infection, pneumonia and necrotizing fasciitis7.

About Group A Strep

Group A Streptococcus, often referred to as group A strep or GAS, is a type of bacterium commonly found in the throat, nose and on skin that can cause a variety of infections5,6. Group A strep infections can occur at any time, but some infections are more common seasonally in the United States. For example, strep throat and scarlet fever are more common in winter and spring, and impetigo is more common in summer7.

There are two primary ways to prevent group A strep from spreading or worsening:

  • Wash your hands often, especially after coughing or sneezing and before preparing foods or eating
  • Treat group A strep infections like strep throat and scarlet fever with antibiotics
    • Note: if you are diagnosed with a group A strep infection, stay home until you have taken antibiotics for at least 24 hours to avoid spreading the infection to others7.

Importance of Group A Strep Testing

Group A strep can cause a variety of illnesses, some deadly, which makes rapid clinical testing vital. According to the Centers for Disease Control and Prevention (CDC)2, an untreated group A strep infection can result in complications including abscesses, secondary sinus or ear infections, and rheumatic fever. In addition, properly diagnosing the source of potential group A strep infection can eliminate unnecessary or inappropriate antibiotic use.

Testing Methods

In the instance of a suspected sore throat caused by a group A strep infection1, a rapid antigen detection test is performed, and negative results are confirmed with a throat culture. While commonly ordered and easy to perform, culture tests can take precious time to confirm or deny a diagnosis. Molecular diagnostic technologies can provide laboratories with fast results that are specific and sensitive to genes produced by group A strep. With test results in under an hour that do not need culture confirmation, patients can leave the clinic with appropriate treatment the same day.

Molecular Diagnostic Group A Strep Testing

Multiple molecular diagnostic assays are available to quickly detect group A strep from a patient’s sample:

  • Cepheid Xpert® Xpress Strep A assay detects group A strep and can provide positive results in as little as 18 minutes from the start of the test3.
  • DiaSorin Molecular’s Simplexa® Group A Strep Direct Kit offers laboratories an assay which showed4 greater than 97% sensitivity when compared to the corresponding sample cultures.

Traditional Culture Group A Strep Testing

Although rapid diagnostic instruments are becoming more common, some clinical laboratories continue to rely on traditional culture methods for detecting group A strep including:

  • Rapid strep screens
  • Throat cultures (maybe also be used to verify negative rapid strep screens)

Controls for Group A Strep Testing

Microbiologics offers a variety of quality control products to help your laboratory ensure accurate results when testing for group A strep including:

Read Next – Research Use Only or IVD: What’s Right for Your Lab?

 

Resources

1: https://www.cdc.gov/groupastrep/diseases-public/strep-throat.html

2: https://www.cdc.gov/groupastrep/diseases-public/strep-throat.html#complications

3: http://www.cepheid.com/us/cepheid-solutions/clinical-ivd-tests/critical-infectious-diseases/xpert-xpress-strep-a

4: https://molecular.diasorin.com/us/kit/simplexa-group-a-strep-direct-kit/

5: https://www.health.ny.gov/diseases/communicable/streptococcal/group_a/fact_sheet.htm

6: https://www.cdc.gov/groupastrep/diseases-public/index.html

7: https://www.cdc.gov/groupastrep/surveillance.html

 

Written by Ashley Umlauf

Ashley Umlauf joined the Molecular R&D team at Microbiologics in July 2016. Ashley is developing new products including instrument control panels using a variety of molecular biology-based techniques such as qPCR and molecular cloning. In addition, Ashley has experience in method validation, GMO product testing, and array-based high throughput genotyping. In 2012, Ashley earned a Bachelor of Science degree in Biochemistry and Molecular Biology with a minor in Anthropology from the University of Wisconsin-Eau Claire.

You May Also Like

0 Comments

Trackbacks/Pingbacks

  1. Dear Stanley: Assayed vs Unassayed Molecular Controls – Microbiologics Blog - […] Read Next: Clinical Case File – Group A Streptococcus […]
Share This